denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: Challenging Situations for Patients with Aggressive Lymphomas
Hematology Disease Topics & Pathways:
Biological, antibodies, therapy sequence, Adult, Diseases, Non-Biological, neurotoxicity, Therapies, Combinations, chemotherapy, Adverse Events, Biological Processes, T-Cell Lymphoma, Technology and Procedures, epigenetics, cytogenetics, Lymphoid Malignancies, Study Population, Clinically relevant, transplantation
Session: Challenging Situations for Patients with Aggressive Lymphomas
Hematology Disease Topics & Pathways:
Biological, antibodies, therapy sequence, Adult, Diseases, Non-Biological, neurotoxicity, Therapies, Combinations, chemotherapy, Adverse Events, Biological Processes, T-Cell Lymphoma, Technology and Procedures, epigenetics, cytogenetics, Lymphoid Malignancies, Study Population, Clinically relevant, transplantation
Saturday, December 5, 2020, 11:55 AM-12:00 PM
Disclosures: Pinter-Brown: Seattle Genetics: Membership on an entity's Board of Directors or advisory committees; Acrotech Biopharma: Consultancy, Membership on an entity's Board of Directors or advisory committees.
OffLabel Disclosure:
See more of: Challenging Situations for Patients with Aggressive Lymphomas
See more of: Education Program
See more of: Education Program